Burn injuries - Is antithrombin back on stage in critical care?

Thrombosis and Haemostasis

Volumn 100, Issue 2, 2008, Pages 177-178

  Korte, Wolfgang ^a,b   Graf, Lukas ^a  

^a Kantonsspital St Gallen ^*  (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; HEPARIN;

BLOOD CLOTTING DISORDER; BURN; CLINICAL TRIAL; DISEASE SEVERITY; DRUG INHIBITION; DRUG MECHANISM; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; INTENSIVE CARE; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL;

ACUTE DISEASE; ANIMALS; ANTITHROMBINS; BLOOD COAGULATION DISORDERS; BURNS; CRITICAL CARE; HUMANS;

EID: 49049111601     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-07-0433     Document Type: Editorial

References (18)

1. Lavrentieva A, Kontakiotis T, Bitzani M, et al. The efficacy of antithrombin administration in the acute phase of burn injury. Thromb Haemost 2008; 286-290.
2. Alkjaersig N, Fletcher AP, Peden JC, et al. Fibrinogen catabolism in burned patients. Trauma 1980; 20: 154-159.
3. Kowal-Vern A, Gamelli RL, Walenga JM, et al. The effect of burn wound size on hemostasis: a correlation of the hemostatic changes to the clinical state. Trauma 1992; 33: 50-57.
4. Ueyama M, Yamamoto I, Sawada Y. Disseminated intravascular coagulation in the early stage after severe burn: the role of excessive thrombin generation. Nippon Geka Gakkai zasshi 1991; 92: 907-912.
5. Neely AN, Warden GD, Rieman M, et al. Components of the increased circulating proteolytic activity in pediatric burn patients. Trauma 1992; 33: 807-812.
6. Prager MD, Baxter CR, Hartline B. Proteolytic activity in burn wound exudates and comparison of fibrin degradation products and protease inhibitors in exudates and sera. J Burn Care Rehabil 1994; 15: 130-136.
7. Neely AN, Miller RG, Holder IA. Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition. Inf Immun 1994; 62: 2158-2164.
8. Okada Y, Zuo XJ, Marchevsky AM, et al. Antithrombin III treatment improves parameters of acute inflammation in a highly histoincompatible model of rat lung allograft rejection. Transplantation 1999; 67: 526-528.
9. Danielsson P, Nilsson L, Nettelblad H et. Is there a need for antithrombin III substitution early after burn injury? Burns 1997; 23: 300-305.
10. Kowal-Vern A, McGill V, Walenga JM, et al. Antithrombin(H) concentrate infusions are safe and effective in patients with thermal injuries. J Burn Care Rehabil 2000; 21: 115-127.
11. Kowal-Vern A, Walenga JM, McGill V, et al. The impact of antithrombin (H) concentrate infusions on pulmonary function in the acute phase of thermal injury. Burns 2001; 27: 52-60.
12. Murakami K, McGuire R, Cox RA, et al. Recombinant antithrombin attenuates pulmonary inflammation following smoke inhalation and pneumonia in sheep. Crit Care Med 2003; 31: 577-583.
13. Murakami K, Enkhbaatar P, Shimoda K, et al. High-dose heparin fails to improve acute lung injury following smoke inhalation in sheep. Clin Sci (Lond) 2003; 104: 349-356.
14. Del Principe D. Antithrombin III in burned children. Minerva Anestesiologica 2003; 69: 376-380.
15. Niedermayr M, Schramm W, Kamolz L, et al. Antithrombin deficiency and its relationship to severe burns. Burns 2007; 33: 173-178.
16. Lavrentieva A, Kontakiotis T, Bitzani M, et al. Early coagulation disorders after severe burn injury: impact on mortality. Int Care Med 2008; 34: 700-706.
17. Warren BL, Eid A, Singer P, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. J Am Med Assoc 2001; 286: 1869-1878.
18. Kienast J, Juers M, Wiedermann CJ, et al. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 2006; 4: 90-97.